Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The biopharmaceutical company said European sales revenue rose to EUR 9.0 million in the first half of 2026 and EBITDA from continuing operations improved to EUR 1.7 million. It also reported record Ameluz unit sales in Germany and higher cash of EUR 7.1 million.
Biofrontera AG said its half-year 2026 report (01.01—30.06.2026) will be published on 30.09.2026 at its website.Material DetailsContext by AI AnalystThis is a routine disclosure signaling imminent release of financial details. The actual numbers, trends, and any guidance within the report would det…